ASP1
US6162630A · kind A · utility
31Cited by
0References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 4, 1999 |
| Grant date | Dec 19, 2000 |
| Priority date | — |
| Expiry date | Nov 4, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K48/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
ASP1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ASP1 polypeptides and polynucleotides in the design of protocols for the treatment of Alzheimers's Disease, cancer, and melanoma, among others, and diagnostic assays for such conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.